Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
Preoperative anemia, bleeding and transfusions have been recognized as a "Deadly triad" in
cardiac surgery associated with an increased morbidity,mortality, and costs related. Thus
strategies to reduce unnecessary RBC transfusions and to optimize preoperative anemia must be
developed .The study evaluate an individual blood conservation strategy based on patient
blood management bundles in cardiac surgery patients: optimisation perioperative hemoglobin
level by erythropoietin and ferric carboxymaltose (Ferinject) associated with the use of
ScV02 to guide perioperative erythrocyte transfusion.